Search research articles
Contact Us
Filters
Showing results (61-70 of 128) with videos related to
Page
of 13
Sort By:
BMC Cancer
|
November 28, 2024
Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection
Shinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Journal of Gastrointestinal Cancer
|
December 18, 2021
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
Toru Aoyama, Masato Nakazono, Kenki Segami, et al.
In Vivo (Athens, Greece)
|
April 28, 2025
Modified Advanced Lung Cancer Inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment
Toru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
In Vivo (Athens, Greece)
|
June 27, 2025
The Usefulness of the Modified Advanced Lung Cancer Inflammation Index (mALI) as a Prognostic Factor in Patients With Esophageal Cancer who Have Undergone Curative Resection
Sosuke Yamamoto, Toru Aoyama, Yukio Maezawa, et al.
In Vivo (Athens, Greece)
|
June 27, 2023
Can Clinical Stage in the 8<sup>th</sup> Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?
Hayato Watanabe, Shinichi Hasegawa, Yuta Kumazu, et al.
Anticancer Research
|
March 27, 2024
Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy
Shinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
In Vivo (Athens, Greece)
|
June 23, 2022
The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
Toru Aoyama, Miwa Ju, Keisuke Komori, et al.
In Vivo (Athens, Greece)
|
March 4, 2022
The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment
Toru Aoyama, Keisuke Komori, Masato Nakazano, et al.
Anticancer Research
|
April 3, 2020
Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation Treatment
Toru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 25, 2018
[Gallbladder Malignant Lymphoma Diagnosed after Surgery for Acute Cholecystitis - A Case Report]
Yuna Sudo, Ryo Takagawa, Kaori Kohagura, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 128) with videos related to
Sort By:
Page
of 13
BMC Cancer
|
November 28, 2024
Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection
Shinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Journal of Gastrointestinal Cancer
|
December 18, 2021
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
Toru Aoyama, Masato Nakazono, Kenki Segami, et al.
In Vivo (Athens, Greece)
|
April 28, 2025
Modified Advanced Lung Cancer Inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment
Toru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
In Vivo (Athens, Greece)
|
June 27, 2025
The Usefulness of the Modified Advanced Lung Cancer Inflammation Index (mALI) as a Prognostic Factor in Patients With Esophageal Cancer who Have Undergone Curative Resection
Sosuke Yamamoto, Toru Aoyama, Yukio Maezawa, et al.
In Vivo (Athens, Greece)
|
June 27, 2023
Can Clinical Stage in the 8<sup>th</sup> Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?
Hayato Watanabe, Shinichi Hasegawa, Yuta Kumazu, et al.
Anticancer Research
|
March 27, 2024
Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy
Shinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
In Vivo (Athens, Greece)
|
June 23, 2022
The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
Toru Aoyama, Miwa Ju, Keisuke Komori, et al.
In Vivo (Athens, Greece)
|
March 4, 2022
The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment
Toru Aoyama, Keisuke Komori, Masato Nakazano, et al.
Anticancer Research
|
April 3, 2020
Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation Treatment
Toru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 25, 2018
[Gallbladder Malignant Lymphoma Diagnosed after Surgery for Acute Cholecystitis - A Case Report]
Yuna Sudo, Ryo Takagawa, Kaori Kohagura, et al.
Page
of 13